Implementation of the Medicare Drug Price Negotiation Program
Description
On June 30, 2023, CMS issued its final guidance memorandum on the implementation of the Inflation Reduction Act Medicare Drug Price Negotiation Program for the Initial Price Applicability Year of 2026. This memorandum is the latest development in the accelerated implementation of the negotiation program, issued just four months after CMS released an initial draft of the guidance memorandum, which generated substantial stakeholder feedback. In this webinar, participants will hear the reactions to the final guidance from Margaux Hall of Ropes & Gray, LLP and Clay Willis of Berkeley Research Group. The speakers will also provide insights into key considerations for manufacturers heading into the negotiation process for the initial year and what this may mean for later years of the program.
